Abstract
The treatment of chronic hepatitis C virus (HCV) infection is vital in patients co-infected with HIV, because end-stage liver disease is a leading cause of mortality in this population. The response to HCV therapy depends on the viral load and genotype. Patients with HCV genotypes 2/3 and low HCV-RNA titres show greater response rates, and may be treated for just 6 months, which is useful in HIV-co-infected patients, in whom anti-HCV drugs are toxic and may interact with antiretroviral agents.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 493-495 |
| Number of pages | 3 |
| Journal | AIDS |
| Volume | 16 |
| Issue number | 3 |
| DOIs | |
| State | Published - Feb 15 2002 |
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Infectious Diseases
Fingerprint
Dive into the research topics of 'Virological characteristics of hepatitis C virus infection in HIV-infected individuals with chronic hepatitis C: Implications for treatment'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS